Belimumab prefilled syringe bulk supplier for pharma manufacturers

Belimumab Prefilled Syringe Suppliers & Bulk Manufacturers

Available Forms: Subcutaneous (SC) and intravenous (IV) Prefilled syringe

Available Strengths: 200 mg/ten 1 mL for SQ; 10 mg/mL for IV

Reference Brands: Benlysta(US & EU)

Belimumab is a monoclonal antibody that inhibits BLyS, a cytokine vital for B-cell survival. It reduces abnormal B-cell activity, autoantibody production, and inflammation in systemic lupus erythematosus (SLE). Benefits include decreased disease activity, fewer flares, improved quality of life, and targeted immune modulation with manageable side effects.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Belimumab, marketed as Benlysta, is approved in the US by the FDA and in the EU via EMA for treating active systemic lupus erythematosus (SLE). Regulatory approval requires a comprehensive dossier including clinical trial data, safety profiles, manufacturing processes, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical and manufacturing information, while the EMA ensures regional compliance with safety and quality standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring thorough regulatory compliance is essential for the safe, effective, and timely approval of belimumab prefilled syringe products worldwide, supporting advanced autoimmune disease management.

Belimumab Prefilled Syringe — third party manufacturing & bulk supply

Belimumab Prefilled Syringe is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Belimumab Prefilled Syringe is supplied as Subcutaneous (SC) and intravenous (IV) Prefilled syringe — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Belimumab Prefilled Syringe listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Belimumab Prefilled Syringe →

Back to Listing

Frequently Asked Questions

Belimumab prefilled syringe is listed as Subcutaneous (SC) and intravenous (IV) Prefilled syringe in 200 mg/ten 1 mL for SQ; 10 mg/mL for IV. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Belimumab prefilled syringe is referenced against Benlysta(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.